Radiation/nuclear medical countermeasure (MCM) product development support services: task order e-2, formulation of recombinant human pleiotrophin (rhptn), 8/5/16-2/28/17

Ended Awarded Last action

Contract number
HHSN27200004
Awardee
Awarding agency
Obligated
$386,275

Award facts

Opportunity
Contract value 100% obligated
$386,275.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00007 -$11,594
Other Administrative Action P00006 · To revise article b.3., advance understandings, subcontract, article c.1., statement of work, section j - list of attachments, and article f.2., reporting… $0
Other Administrative Action P00005 · To revise article f.1., period of performance, to extend the period of performance. $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $397,869

About this award

Written by GovTribe AI ·

This federal contract award to SRI International, a non-profit research and development institute, is for Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services. The task order, valued at $386,275.00, is to revise various articles related to the statement of work, reporting requirements, and other administrative aspects of the broader Radiation/Nuclear MCM Product Development Support Services contract. The contract is cost-plus-fixed-fee and was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency. SRI International has extensive experience providing advanced scientific and technical services to the U.S. federal government through both contracts and grants. This task order does not have a small business set-aside designation.

Quick answers

Who was awarded contract HHSN27200004?

HHSN27200004 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 5, 2016.

How much is contract HHSN27200004 worth?

The government has obligated $386,275 on HHSN27200004.

Is contract HHSN27200004 an order under another contract?

Yes. HHSN27200004 is a delivery order under HHSN272201500013I, an indefinite delivery contract.

Was contract HHSN27200004 competed?

The extent of competition for HHSN27200004 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login